The SLC13A2 gene gives instructions for a transporter that helps the kidneys and intestines take back citrate and related small acids from urine and food. This gene helps your body keep a healthy balance of these substances, which supports normal energy use and can reduce the chance that crystals form in urine. If the gene does not work well, some people may lose more citrate in the urine, which can increase the risk of kidney stones. SLC13A2 is mainly discussed in medical and genetics settings rather than in everyday public culture.
What is a gene?
Genes are stretches of DNA that give cells instructions for making molecules or for regulating activities in the body. Some genes provide the code to produce proteins, which do much of the cell’s work. Others mainly control when, where, and how much certain processes take place. Together, genes affect how the body develops and functions, and they can shape your response to food, stress, and medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
SLC13A2Gene function
What if the gene works
The SLC13A2 gene helps kidney and intestinal cells move citrate and similar small acids into the body. This supports normal handling of nutrients and helps control citrate levels in urine.
Risk
What if the gene does not work
Depending on the variant, changes in the SLC13A2 gene can mildly or more strongly reduce kidney cell uptake of citrate and related small acids. This lowers transporter activity and changes how these molecules are reclaimed from urine.
Treatment
What does that mean for your treatment
No SLC13A2-specific treatment or management approach is currently established in clinical guidelines. Care is usually based on the person's symptoms, such as standard kidney stone prevention and treatment, rather than on a pathogenic variant in the SLC13A2 gene itself. The SLC13A2 gene is being studied as a possible drug target to change citrate handling in the kidneys, which could one day help with stone prevention.
Gene function
What if the gene works
Your kidneys and intestines use the SLC13A2 gene to move certain small acids from the fluid outside cells back into the body. Its protein sits in the cell membrane and pulls in citrate and related molecules together with sodium. This is a key part of how the SLC13A2 gene works in the kidney and small intestine.
In the kidney, the SLC13A2 gene helps cells take citrate back from forming urine. This allows the body to hold on to a useful molecule instead of losing it.
Its protein also carries other small acids, including succinate and alpha-ketoglutarate, into cells along with sodium. This transport happens through the cell membrane as part of normal everyday kidney and gut function.
In the small intestine, this transporter helps absorb some of these molecules from food after digestion. That supports the body’s ability to reuse nutrients that enter the gut.
By reclaiming citrate and related molecules, your body keeps access to compounds that feed normal energy-making pathways. These molecules also help supply raw material for routine cell chemistry.
What is a variant?
A genetic variant means there is a slight difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, such as differences in appearance, metabolism, or the body's response to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. At times, however, a variant can affect how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In discussions of how SLC13A2 variants affect citrate transport, changes in the SLC13A2 gene can alter the transport protein's shape, stability, or ability to reach the cell surface. Milder variants may leave some transport activity in place, while more severe loss-of-function variants can greatly reduce or fully block movement of citrate and related small molecules into the cell. This functional range can lead to different levels of cellular impact.
How variants are linked to conditions
The SLC13A2 gene does not yet have a broadly confirmed link to a specific health condition, although research on how variants of the SLC13A2 gene are linked to conditions is still developing. If you have a confirmed change in the SLC13A2 gene, your doctor or genetic counselor can explain what it may or may not mean for your health in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widespread in the general population. Most do not have a direct effect on health and simply reflect normal human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk directly related to the SLC13A2 gene. Anyone concerned about kidney stone risk or a family history of related problems should speak with a doctor or genetic counselor.
Inheritance of SLC13A2 variants
There is not yet a broadly confirmed disease specific SLC13A2 inheritance pattern used in routine clinical genetics, so how SLC13A2 gene variants are inherited is not usually described with a single established mode such as autosomal dominant or autosomal recessive. As research develops, this picture may become clearer. The SLC13A2 gene is located on chromosome 17, which is an autosome, so you inherit one copy from each parent regardless of sex.
What does my SLC13A2 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific condition for the SLC13A2 gene, though this can become clearer as research develops. If you have a specific SLC13A2 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your relatives and health history.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the SLC13A2 gene, genetic testing for SLC13A2 variants uses a blood or saliva sample. A lab reads the DNA code in this gene and compares it with the usual sequence to identify variants, then classifies findings as benign, uncertain, or disease-causing when evidence is strong.
When should I consider getting a genetic test?
There isn't yet a broadly established SLC13A2-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal or family history, especially with repeated kidney stones or unexplained kidney problems, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
How much a genetic result can tell you varies by the condition and by the kind of variant involved, even though it can provide valuable insight. The body’s function over time is shaped by many factors, including lifestyle, environment, age, and medical history. With some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when viewed together with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, transports, or reacts to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medication or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support more informed, more individualized treatment decisions. More detailed information about this topic is available in the LearnHub.
Drugs influenced by the SLC13A2 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so questions about medicines, side effects, or your overall health are best discussed with your doctor.